glp 1 agonist drugs mechanism of action Frontiers Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
PMID: 27149163
In the stomach, stimulation of gastric -cells leads to somatostatin release, resulting in reduced gastric acid secretion and delayed gastric emptying (Figure 1A)
B., Florez J
Botfield HF, Uldall MS, Westgate C, Mitchell JL, Hagen SM, Gonzalez AM, et al
The Neuroprotection of Liraglutide Against Ischaemia-Induced Apoptosis Through the Activation of the PI3K/AKT and MAPK Pathways
The high prevalence of metabolic disorders and early adoption of novel therapeutics contribute to the regional market dominance
